The lack of a placebo effect in a trial of fluoxetine in the treatment of fibromyalgia [1] (multiple letters)

American Journal of Medicine

Volumn 113, Issue 7, 2002, Pages 614-

  Zijlstra, Theo R ^a   Van de Laar, Mart A F J ^a   Welge, Jeffrey A ^b   Arnold, Lesley M ^b   Hudson, James I ^c,d  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MCLEAN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CYCLOBENZAPRINE; FLUOXETINE; MOCLOBEMIDE;

DEPRESSION; DRUG EFFECT; DRUG EFFICACY; FATIGUE; FIBROMYALGIA; HUMAN; LETTER; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; SLEEP;

EID: 0036851519     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(02)01247-0     Document Type: Letter

References (4)

1. L.M. Arnold E.V. Hess J.I. Hudson A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia Am J Med 112 2002 191 197
2. R.M. Bennett R.A. Gatter S.M. Campbell A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study Arthritis Rheum 31 1988 1535 1542
3. S. Carette M.J. Bell W.J. Reynolds Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial Arthritis Rheum 37 1994 32 40
4. P. Hannonen K. Malminiemi U. Yli-Kerttula A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder Br J Rheumatol 37 1998 1279 1286